Form 8-K - Current report:
SEC Accession No. 0001628280-25-001226
Filing Date
2025-01-13
Accepted
2025-01-13 07:05:09
Documents
63
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fhtx-20250113.htm   iXBRL 8-K 37686
2 EX-99.1 ex991pressreleaseissuedonj.htm EX-99.1 28496
3 EX-99.2 ex992investorpresentatio.htm EX-99.2 45053
7 GRAPHIC ex992investorpresentatio001.jpg GRAPHIC 76143
8 GRAPHIC ex992investorpresentatio002.jpg GRAPHIC 281985
9 GRAPHIC ex992investorpresentatio003.jpg GRAPHIC 79293
10 GRAPHIC ex992investorpresentatio004.jpg GRAPHIC 116498
11 GRAPHIC ex992investorpresentatio005.jpg GRAPHIC 117232
12 GRAPHIC ex992investorpresentatio006.jpg GRAPHIC 122221
13 GRAPHIC ex992investorpresentatio007.jpg GRAPHIC 128718
14 GRAPHIC ex992investorpresentatio008.jpg GRAPHIC 125897
15 GRAPHIC ex992investorpresentatio009.jpg GRAPHIC 141460
16 GRAPHIC ex992investorpresentatio010.jpg GRAPHIC 96400
17 GRAPHIC ex992investorpresentatio011.jpg GRAPHIC 91260
18 GRAPHIC ex992investorpresentatio012.jpg GRAPHIC 74338
19 GRAPHIC ex992investorpresentatio013.jpg GRAPHIC 78409
20 GRAPHIC ex992investorpresentatio014.jpg GRAPHIC 69050
21 GRAPHIC ex992investorpresentatio015.jpg GRAPHIC 122762
22 GRAPHIC ex992investorpresentatio016.jpg GRAPHIC 109185
23 GRAPHIC ex992investorpresentatio017.jpg GRAPHIC 82577
24 GRAPHIC ex992investorpresentatio018.jpg GRAPHIC 115422
25 GRAPHIC ex992investorpresentatio019.jpg GRAPHIC 92856
26 GRAPHIC ex992investorpresentatio020.jpg GRAPHIC 115395
27 GRAPHIC ex992investorpresentatio021.jpg GRAPHIC 108919
28 GRAPHIC ex992investorpresentatio022.jpg GRAPHIC 97320
29 GRAPHIC ex992investorpresentatio023.jpg GRAPHIC 94619
30 GRAPHIC ex992investorpresentatio024.jpg GRAPHIC 92201
31 GRAPHIC ex992investorpresentatio025.jpg GRAPHIC 62889
32 GRAPHIC ex992investorpresentatio026.jpg GRAPHIC 106701
33 GRAPHIC ex992investorpresentatio027.jpg GRAPHIC 109848
34 GRAPHIC ex992investorpresentatio028.jpg GRAPHIC 123864
35 GRAPHIC ex992investorpresentatio029.jpg GRAPHIC 121357
36 GRAPHIC ex992investorpresentatio030.jpg GRAPHIC 117734
37 GRAPHIC ex992investorpresentatio031.jpg GRAPHIC 66166
38 GRAPHIC ex992investorpresentatio032.jpg GRAPHIC 115991
39 GRAPHIC ex992investorpresentatio033.jpg GRAPHIC 89449
40 GRAPHIC ex992investorpresentatio034.jpg GRAPHIC 129927
41 GRAPHIC ex992investorpresentatio035.jpg GRAPHIC 75332
42 GRAPHIC ex992investorpresentatio036.jpg GRAPHIC 116841
43 GRAPHIC ex992investorpresentatio037.jpg GRAPHIC 96540
44 GRAPHIC ex992investorpresentatio038.jpg GRAPHIC 63852
45 GRAPHIC ex992investorpresentatio039.jpg GRAPHIC 114453
46 GRAPHIC ex992investorpresentatio040.jpg GRAPHIC 113460
47 GRAPHIC ex992investorpresentatio041.jpg GRAPHIC 113834
48 GRAPHIC ex992investorpresentatio042.jpg GRAPHIC 62277
49 GRAPHIC ex992investorpresentatio043.jpg GRAPHIC 90614
50 GRAPHIC ex992investorpresentatio044.jpg GRAPHIC 89985
51 GRAPHIC ex992investorpresentatio045.jpg GRAPHIC 115219
52 GRAPHIC ex992investorpresentatio046.jpg GRAPHIC 73789
53 GRAPHIC ex992investorpresentatio047.jpg GRAPHIC 51915
54 GRAPHIC ex992investorpresentatio048.jpg GRAPHIC 90531
  Complete submission text file 0001628280-25-001226.txt   7075916

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20250113.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20250113_lab.xml EX-101.LAB 22543
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20250113_pre.xml EX-101.PRE 13047
65 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20250113_htm.xml XML 2829
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39634 | Film No.: 25524755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)